Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
High Point, NC
SEC filing record 1 source field available
Fiscal year end
31 December
vTv Therapeutics Inc. has filed 595 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 476-500 of 595 matching filings.

Per page
25
Current page
20
4

PRIMARY DOCUMENT

Filing date
03 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 May 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
03 Apr 2017
Reporting date
30 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
29 Mar 2017
Reporting date
29 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
27 Mar 2017
Reporting date
24 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-37524

CT ORDER filing

Filing date
27 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37524

DEFA14A

Filing date
20 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37524

DEF 14A

Filing date
20 Mar 2017
Reporting date
01 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Mar 2017
Reporting date
10 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Mar 2017
Reporting date
10 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Mar 2017
Reporting date
10 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Mar 2017
Reporting date
10 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
28 Feb 2017
Reporting date
27 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-37524

VTVT-10K-12312016

Filing date
24 Feb 2017
Reporting date
31 Dec 2016
Next action
Verify source filing
SC 13G/A File 005-88973

PJC 13GA

Filing date
28 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
15 Dec 2016
Reporting date
14 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
02 Nov 2016
Reporting date
02 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
31 Oct 2016
Reporting date
28 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K

Filing date
17 Aug 2016
Reporting date
16 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37524

8-K GKA RESULTS

Filing date
11 Aug 2016
Reporting date
10 Aug 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
31 May 2016
Reporting date
27 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
24 May 2016
Reporting date
20 May 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .